Form 4: Kindly MD, Inc. COO Adam Cox Reports Acquisition of 40,000 Options

Sentiment:

SEC Form 4 Filing


Adam Cox, COO of Kindly MD, Inc., reports the acquisition of 40,000 options exercisable for common stock.

Summary

  • On May 12, 2025, Adam Cox, the COO and a director of Kindly MD, Inc. acquired 40,000 options.
  • The exercise price of these options is $3.90.
  • The options vest proportionally over a nine-month period ending January 31, 2025.
  • Following the transaction, Cox directly owns 56,304 derivative securities.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing an insider transaction. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This filing is a routine disclosure related to insider transactions and is required by the SEC to ensure transparency in the market. It provides information about the trading activities of company insiders, allowing investors to assess whether those with privileged information are making significant moves in the company's stock.

Stakeholder Impact

  • Shareholders may be interested in this information as it provides insight into the actions of a key executive.

Key Dates

DateDescription
01/31/2025End date of the nine-month vesting period for the options.
05/12/2025Date of the transaction: Adam Cox acquired 40,000 options.
05/14/2025Date of signature for the Form 4 filing.
05/31/2025Date exercisable for options.
05/12/2035Expiration date of the options.

Keywords

Form 4, Insider Trading, Options, Adam Cox, Kindly MD, Inc., KDLY, COO, Director

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.